A Comprehensive Update on Sickle Cell Disease and its Systemic Impact
A new seminar published in The Lancet provides a detailed review of sickle cell disease, a genetic red blood cell disorder affecting millions worldwide. The article emphasizes the complex pathophysiology driven by sickle hemoglobin polymerization, which leads to vaso-occlusion, hemolysis, and chronic inflammation. This cascade results in acute, life-threatening complications like vaso-occlusive crises, acute chest syndrome, and stroke, alongside progressive, chronic damage to virtually all organ systems. The comprehensive update covers the spectrum of these manifestations, offering a crucial resource for understanding the disease’s broad gastrointestinal and hepatic implications, including complications related to the liver and spleen from ongoing hemolysis and ischemia.
Study Significance: For gastroenterologists and hepatologists, this update is vital as sickle cell disease frequently involves the hepatobiliary system, leading to complications such as gallstones, hepatic sequestration, and cholestasis. Understanding the systemic inflammatory and vaso-occlusive drivers can inform the management of related gastrointestinal bleeding, abdominal pain crises, and progressive liver disease in this patient population. This knowledge underscores the need for a multidisciplinary approach to digestive health in patients with complex hematologic disorders.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
